An upper limit for macromolecular crowding effects

First Page		Document Content
Drug safety Health Pharmacy Piperazines Medical terms Adverse drug reaction Adverse effect Pefloxacin Pharmacovigilance Pharmacology Pharmaceutical sciences Medicine		An upper limit for macromolecular crowding effects Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 218,71 KB Share Document on Facebook

	Reference material Standard Workflow for the Revision of Drug Product Package Inserts (Adverse Drug Reaction Reports, etc.) DocID: 1rsP1 - View Document
	Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad DocID: 1rcEG - View Document
	PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division, DocID: 1p9e5 - View Document
	REVIEW ARTICLE A New, Evidence-based Estimate of Patient Harms Associated with Hospital Care John T. James, PhD DocID: 1p3Uj - View Document
	Pharmacovigilance: Monitoring the Safety & Efficacy of Animal Medicines Summary This document DocID: 1oBM7 - View Document